Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.10 14.29% 0.80 1,508,073 16:35:11
Bid Price Offer Price High Price Low Price Open Price
0.70 0.90 0.72 0.72 0.72
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 0.51 -0.36 -0.02 18
Last Trade Time Trade Type Trade Size Trade Price Currency
13:54:30 O 31,857 0.725 GBX

Provexis (PXS) Latest News

More Provexis News
Provexis Investors    Provexis Takeover Rumours

Provexis (PXS) Discussions and Chat

Provexis (PXS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2022-08-11 12:54:310.7331,857230.96O
2022-08-11 11:11:470.7310,84078.59O
2022-08-11 09:05:090.75400,6712,985.00O
2022-08-11 09:04:160.75266,4421,984.99O
2022-08-11 09:02:560.75266,4421,984.99O
View all Provexis trades in real-time

Provexis (PXS) Top Chat Posts

Provexis Daily Update: Provexis Plc is listed in the Food Producers sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.70p.
Provexis Plc has a 4 week average price of 0.68p and a 12 week average price of 0.68p.
The 1 year high share price is 1.10p while the 1 year low share price is currently 0.68p.
There are currently 2,217,821,523 shares in issue and the average daily traded volume is 4,105,979 shares. The market capitalisation of Provexis Plc is £17,742,572.18.
horridhenry: The price for buyout from BH has probably already been agreed subject to Blue hat or whatever they are going for now 5p will do me
winner31: Lots of w’s In the chart above , looks like it wants to move up ,news needed I think !
winner31: Not great volume but something could be brewing .
davemarn: Will this break out of range soon? PVS seems ok for now! Meanwhile people are accumulating 81% been held at June reporting data/date... remarkably more popular than the share price is saying: HTTPS://
gix er: Huntergls, A couple of questions if I may? 1. Has/did the company (PXS) confirm that By-Health has applied for Blue Cap? 2. What did the company say to lead you to believe that "late 2022 early 2023 is key"? Thanks.
redprince: Huntergis - glad you were able to attend and i would have liked to have refreshed some old acquaintances however after far too many years of undeserved largesse on our directors and shareholder apathy i simply dont see the point in attending now. You have said the same thing year after year and this year you were fed an rns to soften shareholders up before the meeting. What you cannot deny is that the bod have taken millions in payment for running a company that has less turnover (and no profit) than a kebab shop on Tottenhan High Road.That has cost us all plenty. The rns has given some clarity as to a potential timeline but we were originally told 2017 so i take the new timeline with a bucket of salt. The only bit of new good news is that we are to supply By-Health directly with FF which by cutting out DSM should improve our share of the profit if IF can negotiate a deal on favourable terms. Noone has managed to ask hpw DSM use exclusivity and under what circumstances it gets dropped - that is what almost certainly cost us the MM Sirco shot deal. I am quite sure noone bothered to ask it (i did previously) no doubt because you were all taken in by the rns. Aimho.
winner31: Https://
bareknee: My thoughts on the results published today :- Overall, those are pretty good results. The increase in revenue from the AA is excellent, though tempered somewhat with a drop in sales in Q1 from this financial year, so we may be flat or thereabouts in the current FY from the AA. That'll become a little clearer when the H1 numbers come out in a few months. FF+ sales are still nothing to write home about in that it only made a contribution to cashflow of 40k (138.2 -49.1 - 48.7 ) though, to be fair, any effect of direct sales in China via the distributor will barely show in those numbers. Another loss is anticipated by the board for the current FY, but it'll hopefully be of the same order, or less, than the year just reported on. We have a bit of flesh on the By-Health calendar as to when they expect to submit on Blue-Hat. Realistically, I think you can add 6 to 18 months to that date before approval is granted, so the earliest we're likely to see that making an effect on our financials is late 2022, with 2023 being more realistic. For the first time in recent years, the end of the current AA agreement we've talked about on here, has been formally mentioned ( well done Ian ) and we have a bit more detail. My expectation is that the agreement will be extended but on slightly different terms, which will hopefully be to our advantage. I'd expect, as Ford is negogiating with DSM, he'll also be looking at potential partnerships with others on the manufacturing side ( By-Health is the obvious candidate ) so we have both a backup plan, and also some leverage with DSM. With a current market cap of 18 million, I don't expect DSM or By-Health to make an offer for us. I'll hold what I've got, but don't feel a burning desire to buy any more. Mind you, the share price is above my last two sales so wtfdik
winner31: Rich i have always thought that DSM have their own agenda when it comes to ff , of course it would be in their interest to not allow the pxs share price to get ahead of itself with regard to market cap ,we all know what happened 10 years or so ago , does anyone else think it’s strange that some years DSM throw £20 or 30k for marketing and so boosting the revenue of pxs and the the next year nothing , so flattening out any spikes in revenue and so the share price , all looks to me like they will make a bid at some stage but only what they want to pay and no more ,may be 3p which in my opinion way under values the potential of the technology .
winner31: Notable News Buzz: Provexis Plc, (LON: PXS) October 18, 2019 No Comments LON: PXSProvexis Plc On Thursday the Provexis Plc, LON: PXS), the Trending-Graph. Every buying and selling session display one-of-a-kind measures and patterns about PXS stock.Now we observed the Many factors that seen on close of the Previous session. Toward the day’s end, it’s only a stock’s show that issues. Summary Of The Provexis Plc In Stock Exchange LON: The PXS share price closed at 0.38 with the change of 0.03 during the period of last trading session. Trading volume can help an investor to identify the momentum in a stock and confirm a trend. If trading volume raised, prices generally move in a similar direction. That is, if security is proceeding higher in an uptrend, the volume of the protection should also increase and vice versa. The Company’s current volume remained at 3424534.00. It will be even better to share yesterday’s volume of the Company, i.e., 1237316.00. Market Capitalization of Provexis Plc : Market Capitalization is the accurate measure of a company’s value. There’s a common misconception that a company’s each-share stock price holds as much importance as its market capitalization when it comes to picking stocks to buy. This fallacy occurs especially often in the case of new investors. The market capitalization of the Company recorded at PXS. Buy/Sell/Hold Analysis of PXS: Buy Signals: An event or condition that alerts a person to place a purchase order for an investment. Buy signals can be either observed by analyzing chart patterns or calculated by trading systems. Hold Signals: An analyst’s recommendation to neither purchase nor sell a security. A company or organization with a hold recommendation mostly is required to perform with the market or a similar pace as comparable companies.
Provexis share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220812 00:51:53